SuperworthConexeu Sciences EPS CNXU
Diluted earnings per share by quarter and over the last twelve months, from 2025.
- Last 12 months, to Jul 31, 2026
- n/m
- a quarter missing
- Latest quarter, Q3 FY26
- −$0.29
Conexeu Sciences' twelve-month earnings per share can't be added up yet: a quarter of its results is missing from our data.
In its latest quarter, Q3 FY26, it was −$0.29.
Earnings per share over time
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier |
|---|---|---|---|
| Q3 FY26 | −$0.29 | n/a | |
| Q2 FY26 | −$0.11 | n/a | |
| Q1 FY26 | −$0.08 | n/a | |
| Q3 FY25 | −$0.09 | n/a | |
| Q2 FY25 | −$0.05 | n/a | |
| Q1 FY25 | −$0.03 | n/a |
Against its peers
Companies in Medical - Instruments & Supplies nearest Conexeu Sciences' size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| CNXUConexeu Sciences | n/m | |
| KEQUKewaunee Scientific | $2.76 | −33% a year |
| APTAlpha Pro Tech | $0.41 | +24% a year |
| PDEXPro DEX | $4.11 | +52% a year |
| NEPHNephros | $0.16 | +33% a year |
| UTMDUtah Medical Products | $3.28 | −12% a year |
| INFUInfuSystem | $0.41 | +78% a year |
| EMBCEmbecta | $1.47 | +3% a year |
| TCMDTactile Systems Technology | $1.08 | +74% a year |
| MDXGMimedx | $0.04 | −81% a year |
| MOVMovado | $1.80 | +137% a year |
| Peer median | $1.27 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Conexeu Sciences
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.